I do worry for anyone who has taken the current rounds of
I do worry for anyone who has taken the current rounds of vaccines as to the issues they are experiencing or what they might experience down the line. Though, it's like playing Russian Roulette apparently, there are people who will be ok.
This is why we need the NGIO vaccine. And it is why we need the IND put in as quickly as possible. It's also why I have a hard time wondering why it's taking so long to get it done, based on they had the pre-IND from before and maybe I am completely wrong, which I have been before, but they should just need to modify that one with the updated information from the GMP results and such. I would think that this should not take weeks or months to do, since they have the experience now. But hey, what do I know? It's just frustrating in the wait.
With so much at stake and with so many players in the game and things moving so fast, it is imperative they get ahead in all of this and get things pushed. Each day puts them further behind. China is the big deal, along with Malaysia, but finishing the IND puts both in China and the US and gives them the ability to start trials in both countries or even one, but gives them the ultimate legitimacy that they needed. Right now, it's still just talk. until they do and the FDA's of both the US and China get the INDs and approve.
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Visual Comfort & Co. Unveils Its Stunning New Showroom Visual Comfort & Co. has proudly announced the launch of its latest showroom, covering an impressive 4,000 square feet. This destination not only features the visionary work of renowned designers but also creates a welcoming environment for customers looking to enhance their spaces with stylish lighting. Designer...
Continue Reading
Event Highlights and Community Impact Event Showcases Innovation, Community, and the Power of Women Entrepreneurs NEW YORK / -- The Enthuse Foundation, a non-profit organization dedicated to empowering a new generation of women entrepreneurs, hosted its 7th Annual Women Founders Pitch Competition recently at The Town Hall by Skylight in the bustling Penn District of New...
Continue Reading
JPMorgan's CEO Expresses Market Anxiety Jamie Dimon, the CEO of JPMorgan Chase & Co. (NYSE:JPM), is voicing serious concerns about the potential for a stock market crash, suggesting that the likelihood is significantly underestimated. During a candid interview, he expressed that he is 'far more worried than others' about the chances of a major market correction....
Continue Reading
Market Prepares for the Impact of the CPI Report This Wednesday, the market is bracing for significant updates, with index futures reflecting a cautious stance. Investors are eagerly anticipating the consumer price index (CPI) data, which could have serious implications for market trends. A recent presidential debate between two prominent candidates has caught the...
Continue Reading
Understanding the Class Action Lawsuit Against Cassava Sciences Investors holding shares in Cassava Sciences, Inc. find themselves at an important juncture as recent developments unfold regarding class action lawsuits against the company. If you are one of the investors who purchased securities of Cassava Sciences, it is crucial to be aware of the impending deadlines to...
Continue Reading